Skip to content

DMT: all studies

Page 121 of 160: studies 1,201 to 1,210 of 1,593, newest first. Back to the DMT overview

Research

Chemical Composition of Traditional and Analog Ayahuasca

Journal of Psychoactive Drugs September 8, 2020 Helle Kaasik, Rita C. Z. Souza, Flávia Da Silva Zandonadi et al. 54 citations

Traditional ayahuasca can be defined as a brew made from Amazonian vine Banisteriopsis caapi and Amazonian admixture plants. Ayahuasca is used by indigenous groups in Amazonia, as a sacrament in syncretic Brazilian religions, and in healing and spiritual ceremonies internationally. The study aimed to determine concentrations of the main bio- and psychoactive components of ayahuasca used in...

Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans

Chronic Stress August 12, 2020 Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda et al. 83 citations

Background U.S. Special Operations Forces Veterans are at increased risk for a variety of mental health problems and cognitive impairment associated with military service. Current treatments are lacking in effectiveness and adherence. Therefore, this study examined psychedelic treatment with ibogaine and 5-methoxy-N,N-dimethyltryptamine for trauma-related psychological and cognitive impairment...

DOI: 10.1177/2470547020939564 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Veteran mental health Trauma recovery Cognitive improvement

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

August 7, 2020 Olga V. Mitina, М.а. Винникова, А. Н. Решетилов et al. preprint

## AimInvestigate accounts from breath-holding freedivers about high efficiency in coping with adversity and pain, immediately quitting addictions, attaining harmonious meaningful life, becoming perspicacious and compassionate, getting spontaneous religious experience. ## Findings Full Mystical Experience is confirmed to happen in freediving, i.e. it is the same Mystical experience found in...

Modulatory effects of ayahuasca on personality structure in a traditional framework

Psychopharmacology July 23, 2020 Nige Netzband, Simon Ruffell, Sabriya Linton et al. 56 citations

Abstract Abstract Ayahuasca is a psychoactive plant brew containing dimethyltryptamine (DMT) and monoamine oxidase inhibitors (MAOIs). It originates from the Amazon basin, where it is used primarily for ceremonial purposes. Ayahuasca tourists are now entering certain communities seeking alternative physical or psychological healing, as well as spiritual growth. Rationale Recent evidence has...

Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms

Journal of Pharmaceutical and Biomedical Analysis July 21, 2020 Izumi Morita, Hiroyuki Oyama, Yuki Kiguchi et al. 17 citations

Development of rapid and reliable immunochemical methods for monitoring psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine; Pyb) and psilocin (dephosphorylated metabolite; Psi), the psychoactive compounds contained within hallucinogenic mushrooms (magic mushrooms), is desirable in order to identify these mushrooms and regulate their illicit use. Because no antibody was publicly available for...

DOI: 10.1016/j.jpba.2020.113485 (opens in new tab) Psilocybin Hallucinogen Monoclonal antibody Metabolite +3

4 Psychedelics: therapeutic mechanisms

Journal of Neurology, Neurosurgery, and Psychiatry July 20, 2020 Robin Carhart-Harris

Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At Imperial, he has designed and/or carried out brain imaging studies involving LSD, psilocybin, MDMA and DMT, plus a clinical trial of psilocybin for treatment-resistant depression, and an ongoing study...

DOI: 10.1136/jnnp-2020-bnpa.4 (opens in new tab) Psilocybin Hallucinogen Psychoanalysis Psychotherapist

Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential

Plants July 9, 2020 Beatriz Werneck Lopes Santos, Regina Célia de Oliveira, Júlia Sonsin‐oliveira et al. 32 citations

Ayahuasca is a psychoactive infusion with a large pharmacological application normally prepared with Banisteriopsis caapi, which contains the monoamine oxidase inhibitors β-carbolines, and Psichotria virids, which contains the serotonin receptor agonist N,N dimethyltryptamine (DMT). The objectives of this study were to investigate the chemical profile of B. caapi and of ayahuasca collected in...

DOI: 10.3390/plants9070870 (opens in new tab) Ayahuasca Harmine Harmaline Malpighiaceae +4

The pharmacological interaction of compounds in ayahuasca: a systematic review

Brazilian Journal of Psychiatry July 3, 2020 Simon Ruffell, Nige Netzband, Catherine Bird et al. 43 citations

Ayahuasca is a South American psychoactive plant brew used as traditional medicine in spiritual and in cultural rituals. This is a review of the current understanding about the pharmacological mechanisms that may be interacting in ayahuasca. Searches were performed using PubMed, PsycINFO, and Web of Science databases and 16 papers were selected. As hypothesized, the primary narrative in...

Molecular docking and binding interaction between psychedelic drugs and human serum albumin

BioTechnologia June 16, 2020 Hossein Khastar, Kobra Foroughi, Seyed Shahrokh Aghayan et al. 3 citations

Drug-plasma protein interaction is a critical concern in monitoring drug circulation and drug-drug interactions. The present study aimed to investigate the interaction of psychedelic drugs such as lysergic acid diethylamide (LSD), dimethyltryptamine (DMT), 2,5-dimethoxy-4-iodoamphetamine (DOI), psilocybin, psilocin, and mescaline with human serum albumin (HSA). The 3D structures of LSD, DMT,...

DOI: 10.5114/bta.2020.94770 (opens in new tab) Docking animal Human serum albumin Plasma protein binding Pharmacology +2

Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.

Journal of Ethnopharmacology June 12, 2020 Albert Katchborian‐neto, Wanderleya T Santos, Karen J Nicácio et al. 62 citations

Ayahuasca is a tea produced through decoction of Amazonian plants. It has been used for centuries by indigenous people of South America. The beverage is considered to be an ethnomedicine, and it is traditionally used for the treatment of a wide range of diseases, including neurological illness. Besides, some scientific evidence suggests it may be applicable to Parkinson's disease (PD)...

DOI: 10.1016/j.jep.2020.112743 (opens in new tab) Full text (opens in new tab) Ayahuasca Metabolomics Neurodegenerative disease Neuroprotection +2